CHGCF - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript
2025-02-01 08:03:01 ET
Chugai Pharmaceutical Co., Ltd. (CHGCF)
Q4 2024 Earnings Conference Call
January 30, 2025 3:30 AM ET
Company Participants
Kae Miyata - Head of Corporate Communications Department
Osamu Okuda - Representative Director, President, and Chief Executive Officer
Michiaki Tanaka - Head, R&D Portfolio Management Department, Project and Lifecycle Management Unit
Iwaaki Taniguchi - Director, Executive Vice President, and Chief Financial Officer
Takao Suzuki - Associate Vice President, Head of the Digital Transformation Unit
Conference Call Participants
Kazuaki Hashiguchi - Daiwa Securities
Fumiyoshi Sakai - UBS Securities
Seiji Wakao - JPMorgan Securities
Hidemaru Yamaguchi - Citigroup Global Markets
Stephen Barker - Jefferies
Tony Ren - Macquarie Capital Securities
Shinichiro Muraoka - Morgan Stanley MUFG Securities
Miki Sogi - AllianceBernstein Japan
Presentation
Kae Miyata
Ladies and gentlemen, thank you for attending the conference on FY 2024 December financial results for Chugai Pharmaceutical. I am acting as a master of ceremony for today. My name is Miyata from the IR Department. We are holding this session in a hybrid manner.
The agenda for today's presentation are shown on the presentation material page three as well as the screen in the venue. However, for those who are participating through Zoom webinar, you will be able to listen to the simultaneous translation [Technical Difficulty] the language of your choice by clicking the button at the bottom of your screen. For those who wish to listen to Japanese, please select Japanese. For those who wish to listen to English, please select English. After selecting your preferred language, please click on mute original audio.
At the beginning of each session, we are going to pause for a while for those who [Technical Difficulty] to take a photo of the screen. We are going to take questions at the very end of the presentation. We allocate about 30 minutes for the Q&A session. Audio is muted during the presentation session.
Now, Okuda will take you through a summary of the year 2024 and the outlook into 2025. We are going to pause for a while before the presentation of Okuda. So for those who wish to take a screen capture, please do so.
Osamu Okuda
Now I'd like to start the presentation. I am Okuda, the President. I'll explain the summary of 2024 and the forecast for 2025....
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript